A randomized trial found adding a family-based component to a weight management program for children in primary care resulted in greater reduction in body mass index.

The FDA has approved Simtriyo (centanafadine) as the first norepinephrine, dopamine, serotonin reuptake inhibitor for adult and pediatric ADHD.

With measles back in Spain and tuberculosis on the rise, emergency physicians are being urged to spot subtle clues early and isolate patients before spread begins.

Susvimo, a refillable ranibizumab implant for neovascular age-related macular degeneration, could reduce treatment burden by ...

Calcium supplementation may not add to the benefits of osteoporosis medications in older women with adequate calcium intake, ...

Adults with psoriasis of varying degrees show a higher burden of myocardial dysfunction than control individuals, a study ...

High baseline nasal IgA, not serum IgG, was linked to lower risk for influenza A H1N1 infection in a real-world study.

Ruxolitinib Viatris and Cavoley moved closer to EU approval, offering a bioequivalent option for hematologic disease and a ...

HSV type 1 reactivation was prevalent among critically ill patients with COVID-19 and was independently associated with ...

More than one third of older adults took five or more prescription medicines in the past month, and this pattern was associated with a 38% increased risk for death. Researchers analyzed data from a US ...

A new meta-analysis finds ceftaroline and ceftobiprole monotherapy show no clear advantage over standard therapy for ...

New decision aids from FIFA help players decide with their doctors how to continue playing safely during pregnancy and ...